Therapeutic Depth: Dermatology

Dedication to Dermatologic Drug & Device Development

Therapeutic Depth: Dermatology

One in five Americans is expected to develop skin cancer in their lifetime,12 and psoriasis and atopic dermatitis are among the most common health conditions in the U.S.3

At Synteract, we draw on longstanding dedication in dermatological drug and device development in complex Phase I-IV clinical trials. We have handled complete project management as well as specific services to address your needs for feasibility, biostatistics, clinical operations, data management, medical writing and more.

Our International expertise, including managing third party vendors such as central labs and drug distributors, can help you to expand site options, improve recruitment and meet regulatory requirements to focus on enabling new treatments to extend and enhance quality of life for patients everywhere.


Contact Synteract

Tell us how to stay in touch with you: